Polymorphism in sulfadimidine/4- aminosalicylic acid cocrystals: solid-state characterization and physicochemical properties
View/ Open
Paluch_Journal_of_Pharmaceutical_Sciences.pdf (413.9Kb)
Download
Publication date
2015-04Author
Grossjohann, C.Serrano, D.R.
Paluch, Krzysztof J.
O'Connell, P.
Vella-Zarb, L.
Manesiotis, P.
McCabe, T.
Tajber, L.
Corrigan, O.I.
Healy, A.M.
Rights
© 2015 Elsevier. Reproduced in accordance with the publisher's selfarchiving policy. This manuscript version is made available under the CC-BY-NC-ND 4.0 license.Peer-Reviewed
YesOpen Access status
openAccessAccepted for publication
2014-12-12
Metadata
Show full item recordAbstract
Polymorphism of crystalline drugs is a common phenomenon. However, the number of reported polymorphic cocrystals is very limited. In this work, the synthesis and solid state characterisation of a polymorphic cocrystal composed of sulfadimidine (SD) and 4- aminosalicylic acid (4-ASA) is reported for the first time. By liquid-assisted milling, the SD:4-ASA 1:1 form I cocrystal, the structure of which has been previously reported, was formed. By spray drying, a new polymorphic form (form II) of the SD:4-ASA 1:1 cocrystal was discovered which could also be obtained by solvent evaporation from ethanol and acetone. Structure determination of the form II cocrystal was calculated using high resolution X-ray powder diffraction. The solubility of the SD:4-ASA 1:1 cocrystal was dependent on the pH and predicted by a model established for a two amphoteric component cocrystal. The form I cocrystal was found to be thermodynamically more stable in aqueous solution than form II, which showed transformation to form I. Dissolution studies revealed that the dissolution rate of SD from both cocrystals was enhanced when compared to a physical equimolar mixture and pure SD.Version
Accepted manuscriptCitation
Grossjohann C, Serrano DR, Paluch KJ et al (2015) Polymorphism in sulfadimidine/4- aminosalicylic acid cocrystals: solid-state characterization and physicochemical properties. Journal of Pharmaceutical Sciences. 104(4): 1385-1398.Link to Version of Record
https://doi.org/10.1002/jps.24345Type
Articleae974a485f413a2113503eed53cd6c53
https://doi.org/10.1002/jps.24345